-
Altarejos JY, Montminy M, 2011: CREB and the CRTC co-activators: sensors for hormonal and metabolic signals[J]. Nat Rev Mol Cell Biol, 12, 141-151. doi: 10.1038/nrm3072
-
Amelio AL, Caputi M, Conkright MD, 2009: Bipartite functions of the CREB co-activators selectively direct alternative splicing or transcriptional activation[J]. EMBO J, 28, 2733-2747. doi: 10.1038/emboj.2009.216
-
Banerjee A, Pirrone V, Wigdahl B, Nonnemacher MR, 2011: Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway[J]. Biomed Pharmacother, 65, 293-297. doi: 10.1016/j.biopha.2011.03.009
-
Banerjee A, Li L, Pirrone V, Krebs FC, Wigdahl B, Nonnemacher MR, 2017: cAMP signaling enhances HIV-1 long terminal repeat (LTR)-directed transcription and viral replication in bone marrow progenitor cells[J]. Clin Med Insights Pathol, 10, 1179555717694535-.
-
Boehm D, Jeng M, Camus G, Gramatica A, Schwarzer R, Johnson JR, Hull PA, Montano M, Sakane N, Pagans S, Godin R, Deeks SG, Krogan NJ, Greene WC, Ott M, 2017: SMYD2-mediated histone methylation contributes to HIV-1 latency[J]. Cell Host Microbe, 21, 569-579. e566. doi: 10.1016/j.chom.2017.04.011
-
Bonni A, Ginty DD, Dudek H, Greenberg ME, 1995: Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals[J]. Mol Cell Neurosci, 6, 168-183. doi: 10.1006/mcne.1995.1015
-
Chun TW, Lieven S, Stephanie BM, Linda AE, Joann MM, Michael B, Alun LL, Martin AN, Anthony SF, 1997: Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy[J]. Proc Natl Acad Sci U S A, 94, 13193-13197. doi: 10.1073/pnas.94.24.13193
-
Coiras M, López-Huertas MR, Pérez-Olmeda M, Alcamí J, 2009: Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs[J]. Nat Rev Microbiol, 7, 798-812. doi: 10.1038/nrmicro2223
-
Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M, 2003: TORCs: transducers of regulated CREB activity[J]. Mol Cell, 12, 413-423. doi: 10.1016/j.molcel.2003.08.013
-
Delannoy A, Poirier M, Bell B, 2019: Cat and mouse: HIV transcription in latency, immune evasion and cure/remission strategies[J]. Viruses, 11, 269-. doi: 10.3390/v11030269
-
Galvin TA, Muller J, Khan AS, 2000: Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina[J]. Vaccine, 18, 2566-2583. doi: 10.1016/S0264-410X(99)00569-1
-
Hu S, Li J, Xu F, Mei S, Yann L, Yin L, Pang X, Cen S, Jin Q, Fei Guo F, 2015: SAMHD1 inhibits LINE-1 retrotransposition by promoting stress granule formation[J]. PLoS Genet, 11, e1005367-. doi: 10.1371/journal.pgen.1005367
-
Iourgenko V, Zhang W, Craig M, Ira D, Jiang C, Jonathan MH, Anthony PO, Loren M, Jodi M, Dan G, Gung-Wei C, Elizabeth MW, Dalia C, Joanne S, Robert T, Yu Y, Dale B, Frank PB, Zhu J, Song C, Mark AL, 2003: Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells[J]. Proc Natl Acad Sci USA, 100, 12147-12152. doi: 10.1073/pnas.1932773100
-
Jabareen A, Suleman M, Abu-Jaafar A, Huleihel M, 2018: Different molecular mechanisms of HTLV-1 and HIV LTR activation by TPA[J]. Biochem Biophys Res Commun, 500, 538-543. doi: 10.1016/j.bbrc.2018.04.062
-
Jiang S, Inada T, Tanaka M, Furuta RA, Shingu K, Fujisawa JI, 2009: Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1[J]. Retrovirology, 6, 73-73. doi: 10.1186/1742-4690-6-73
-
Karn J, Stoltzfus CM, 2012: Transcriptional and posttranscriptional regulation of HIV-1 gene expression[J]. Cold Spring Harb Perspect Med, 2, a006916-a006916.
-
Keedy KS, Archin NM, Gates AT, Espeseth A, Hazuda DJ, Margolis DM, 2009: A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression[J]. J Virol, 83, 4749-4756. doi: 10.1128/JVI.02585-08
-
Khoury G, Darcis G, Lee MY, Bouchat S, Van Driessche B, Purcell DFJ, Van Lint C, 2018: The molecular biology of HIV latency[J]. Adv Exp Med Biol, 1075, 187-212.
-
Kim YM, Geiger TR, Egan DI, Sharma N, Nyborg JK, 2010: The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription[J]. Oncogene, 29, 2142-2152. doi: 10.1038/onc.2009.498
-
Koseki S, Ohkawa J, Yamamoto R, Takebe Y, Taira K, 1998: A simple assay system for examination of the inhibitory potential in vivo of decoy RNAs, ribozymes and other drugs by measuring the Tat-mediated transcription of a fusion gene composed of the long terminal repeat of HIV-1 and a gene for luciferase[J]. J Control Release, 53, 159-173. doi: 10.1016/S0168-3659(97)00250-2
-
Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano RF, 2004: The multifactorial nature of HIV-1 latency[J]. Trends Mol Med, 10, 525-531. doi: 10.1016/j.molmed.2004.09.006
-
Li C, Wang HB, Kuang WD, Ren XX, Song ST, Zhu HZ, Li Q, Xu LR, Guo HJ, Wu L, Wang JH, 2016: Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells[J]. J Virol, 91, e01830-e11816.
-
Li X, Zhang J, Jia R, Vicky C, Xu X, Qiao W, Guo F, Liang C, Cen S, 2013: The MOV10 helicase inhibits LINE-1 mobility[J]. J Biol Chem, 288, 21148-21160. doi: 10.1074/jbc.M113.465856
-
Liu Y, Renaud D, Danica C, Susan H, Kim R, Simon S, Jill M, David JM, Phil C, John Y, Jerrold O, Leonard G, Marc M, 2008: A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange[J]. Nature, 456, 269-273. doi: 10.1038/nature07349
-
Ma L, Sun L, Jin X, Xiong SD, Wang JH, 2018a: Scaffold attachment factor B suppresses HIV-1 infection of CD4(+) T cells by preventing binding of RNA polymerase Ⅱ to HIV-1's long terminal repeat[J]. J Biol Chem, 293, 12177-12185. doi: 10.1074/jbc.RA118.002018
-
Ma L, Zhang Z, Liu Z, Pan Q, Wang J, Li X, Guo F, Liang C, Hu L, Zhou J, Cen S, 2018b: Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation[J]. Sci Rep, 8, 8067-8067. doi: 10.1038/s41598-018-26318-3
-
Margolis DM, 2010: Mechanisms of HIV latency: an emerging picture of complexity[J]. Curr Opin HIV AIDS, 7, 37-43. doi: 10.1007/s11904-009-0033-9
-
Murata T, Sato Y, Nakayama S, Kudoh A, Iwahori S, Isomura H, Tajima M, Hishiki T, Ohshima T, Hijikata M, Shimotohno K, Tsurumi T, 2009: TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein[J]. J Biol Chem, 284, 8033-8041. doi: 10.1074/jbc.M808466200
-
Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D, 1996: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector[J]. Science, 272, 263-267. doi: 10.1126/science.272.5259.263
-
Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, Karn J, 2008: Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency[J]. J Virol, 82, 12291-12303. doi: 10.1128/JVI.01383-08
-
Rabbi MF, Saifuddin M, Gu DS, Kagnoff MF, Roebuck KA, 1997: U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins[J]. Virology, 233, 235-245. doi: 10.1006/viro.1997.8602
-
Rafati H, Parra M, Hakre S, Moshkin Y, Verdin E, Mahmoudi T, 2011: Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency[J]. PLoS Biol, 9, e1001206-. doi: 10.1371/journal.pbio.1001206
-
Schiralli Lester GM, Henderson AJ, 2012: Mechanisms of HIV transcriptional regulation and their contribution to latency[J]. Mol Biol Int, 2012, 614120-.
-
Shang HT, Ding JW, Yu SY, Wu T, Zhang QL, Liang FJ, 2015: Progress and challenges in the use of latent HIV-1 reactivating agents[J]. Acta Pharmacol Sin, 36, 908-916. doi: 10.1038/aps.2015.22
-
Siu YT, Chin KT, Siu KL, Yee Wai Choy E, Jeang KT, Jin DY, 2006: TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats[J]. J Virol, 80, 7052-7059. doi: 10.1128/JVI.00103-06
-
Sun WW, Jiao S, Sun L, Zhou Z, Jin X, Wang JH, 2018: SUN2 modulates HIV-1 infection and latency through association with lamin A/C To maintain the repressive chromatin[J]. mBio, 9, e02408-02417.
-
Suzuki N, Yoshida T, Sakuma R, Sukegawa S, Yamaoka S, 2018: Robust enhancement of lentivirus production by promoter activation[J]. Sci Rep, 8, 15036-. doi: 10.1038/s41598-018-33042-5
-
Tang H-MV, Gao WW, Chan CP, Cheng Y, Chaudhary V, Deng JJ, Yuen KS, Wong CM, Ng IO-L, Kok KH, Zhou J, Jin DY, 2014: Requirement of CRTC1 coactivator for hepatitis B virus transcription[J]. Nucleic Acids Res, 42, 12455-12468. doi: 10.1093/nar/gku925
-
Tian X, Zhao F, Sun W, Zhi X, Cheng Z, Zhou M, Hu K, 2014: CRTC2 enhances HBV transcription and replication by inducing PGC1α expression[J]. Virol J, 11, 30-. doi: 10.1186/1743-422X-11-30
-
Trono D, Van Lint C, Rouzioux C, Verdin E, Barré-Sinoussi F, Chun T-W, Chomont N, 2010: HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals[J]. Science, 329, 174-180. doi: 10.1126/science.1191047
-
Tyagi M, Karn J, 2007: CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency[J]. EMBO J, 26, 4985-4995. doi: 10.1038/sj.emboj.7601928
-
Uebi T, Tamura M, Horike N, Hashimoto YK, Takemori H, 2010: Phosphorylation of the CREB-specific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver[J]. Am J Physiol Endocrinol Metab, 299, E413-E425. doi: 10.1152/ajpendo.00525.2009
-
Van Duyne R, Guendel I, Narayanan A, Gregg E, Shafagati N, Tyagi M, Easley R, Klase Z, Nekhai S, Kehn-Hall K, Kashanchi F, 2011: Varying modulation of HIV-1 LTR activity by Baf complexes[J]. J Mol Biol, 411, 581-596. doi: 10.1016/j.jmb.2011.06.001
-
Wang J, Zhang Y, Li Q, Zhao J, Yi D, Ding J, Zhao F, Hu S, Zhou J, Deng T, Li X, Guo F, Liang C, Cen S, 2019: Influenza virus exploits an interferon-independent lncRNA to preserve viral RNA synthesis through stabilizing viral RNA polymerase PB1[J]. Cell Rep, 27, e3294-.
-
Watts AG, Sanchez-Watts G, Liu Y, Aguilera G, 2011: The distribution of messenger RNAs encoding the three isoforms of the transducer of regulated cAMP responsive element binding protein activity in the rat forebrain[J]. J Neuroendocrinol, 23, 754-766. doi: 10.1111/j.1365-2826.2011.02178.x
-
Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van-Lint C, Skiest DJ, Burns DK, Harrod R, 2005: HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB[J]. J Biol Chem, 280, 9390-9399. doi: 10.1074/jbc.M408643200
-
Yi DR, An N, Liu Z, Xu FW, Kavita R, Li QJ, Zhou R, Wang J, Zhang YX, Zhou JM, Zhang LL, An J, Qin CF, Guo F, Li X, Liang C, Cen S, 2019: Human MxB inhibits the replication of hepatitis C virus[J]. J Virol, 93, e01285-e01318.
-
Zhang Z, Klatt A, Gilmour DS, Henderson AJ, 2007: Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase Ⅱ complex[J]. J Biol Chem, 282, 16981-16988. doi: 10.1074/jbc.M610688200